Clinical Trials
5 trialsNCT00915382 2020-01-07
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
Phase 3 Completed
NCT01471470 2020-01-07
Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
Asan Medical Center
Phase 2 Completed
NCT00842491 2015-05-19
Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer
Peking University
Phase 2 Completed
NCT01015339 2015-05-19
Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
Peking University
Phase 3 Unknown
NCT00743964 2010-01-15
Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)
Samsung Medical Center
Phase 2 Completed